|
G |
Apob |
apolipoprotein B |
affects expression |
ISO |
Bendroflumethiazide affects the expression of APOB protein |
CTD |
PMID:2344503 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Ren |
renin |
increases expression |
ISO |
Bendroflumethiazide results in increased expression of REN protein |
CTD |
PMID:62162 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Slc12a3 |
solute carrier family 12 member 3 |
increases response to substance |
EXP |
SLC12A3 protein results in increased susceptibility to Bendroflumethiazide |
CTD |
PMID:18480177 |
|
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases activity increases secretion |
ISO |
Bendroflumethiazide results in decreased activity of SLC22A6 protein SLC22A6 protein results in increased secretion of Bendroflumethiazide |
CTD |
PMID:18216144 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
decreases activity increases secretion |
ISO |
Bendroflumethiazide results in decreased activity of SLC22A8 protein SLC22A8 protein results in increased secretion of Bendroflumethiazide |
CTD |
PMID:18216144 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
decreases activity |
ISO |
Bendroflumethiazide results in decreased activity of TPMT protein |
CTD |
PMID:8866635 |
|
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
|
|
G |
Vegfc |
vascular endothelial growth factor C |
decreases expression |
EXP |
Bendroflumethiazide results in decreased expression of VEGFC protein |
CTD |
PMID:20625077 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
|
G |
Alb |
albumin |
increases secretion multiple interactions |
EXP |
bentazone results in increased secretion of ALB protein [bentazone co-treated with Dicamba] results in increased secretion of ALB protein |
CTD |
PMID:25863332 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
|
G |
Sfrp4 |
secreted frizzled-related protein 4 |
affects binding |
ISO |
cyclothiazide binds to SFRP4 protein |
CTD |
PMID:25019556 |
|
NCBI chr17:45,278,867...45,330,806
Ensembl chr17:45,234,097...45,330,736
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein] |
CTD |
PMID:37783230 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
decreases localization multiple interactions |
EXP ISO |
Diazoxide results in decreased localization of AIFM1 protein 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]]; Diazoxide inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein] 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in decreased localization of AIFM1 protein] |
CTD |
PMID:21256120 PMID:37783230 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
EXP |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:21256120 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
Diazoxide inhibits the reaction [Streptozocin results in increased expression of BAX protein] 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of BAX protein]]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of BAX protein] |
CTD |
PMID:20650802 PMID:37783230 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP ISO |
Diazoxide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]]; Diazoxide inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein] |
CTD |
PMID:20650802 PMID:37783230 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 mRNA alternative form]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 protein alternative form] Diazoxide results in increased expression of BCL2L1 mRNA alternative form; Diazoxide results in increased expression of BCL2L1 protein alternative form |
CTD |
PMID:15326191 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity |
EXP |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in decreased activity of CASP3 protein] |
CTD |
PMID:21256120 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] Diazoxide results in decreased expression of CCND1 mRNA |
CTD |
PMID:19052819 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein] |
CTD |
PMID:37783230 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
Diazoxide inhibits the reaction [CTNNB1 protein results in increased activity of CCND1 promoter] Diazoxide results in decreased expression of CTNNB1 protein |
CTD |
PMID:19052819 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cycs |
cytochrome c, somatic |
decreases secretion multiple interactions |
EXP |
Diazoxide results in decreased secretion of CYCS protein 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in decreased secretion of CYCS protein] |
CTD |
PMID:21256120 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]; HMOX1 protein affects the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]; zinc protoporphyrin inhibits the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]] |
CTD |
PMID:25371888 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Gcg |
glucagon |
multiple interactions |
ISO |
Diazoxide inhibits the reaction [gatifloxacin results in increased secretion of GCG protein] |
CTD |
PMID:23200776 |
|
NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2 |
multiple interactions |
ISO |
[Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:10464266 |
|
NCBI chr 3:41,800,552...41,937,729
Ensembl chr 3:41,801,930...41,936,901
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
Diazoxide inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 mRNA]; Diazoxide inhibits the reaction [Oxygen deficiency results in decreased expression of HMOX1 protein]; HMOX1 protein affects the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]] |
CTD |
PMID:25371888 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Iapp |
islet amyloid polypeptide |
multiple interactions |
EXP |
Diazoxide inhibits the reaction [Glucose results in increased expression of IAPP mRNA] |
CTD |
PMID:9142872 |
|
NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920
|
|
G |
Il10 |
interleukin 10 |
decreases secretion |
ISO |
Diazoxide results in decreased secretion of IL10 protein |
CTD |
PMID:16612254 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il6 |
interleukin 6 |
decreases secretion |
ISO |
Diazoxide results in decreased secretion of IL6 protein |
CTD |
PMID:16612254 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO EXP |
[Potassium Chloride co-treated with Diazoxide] inhibits the reaction [[GPD2 mutant form co-treated with Aminooxyacetic Acid] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein]; Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of INS1 mRNA] |
CTD |
PMID:10464266 PMID:10780946 PMID:11527545 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Diazoxide inhibits the reaction [Glucose results in increased secretion of INS protein] |
CTD |
PMID:35457000 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Kcnj11 |
potassium inwardly-rectifying channel, subfamily J, member 11 |
decreases expression |
ISO |
Diazoxide results in decreased expression of KCNJ11 mRNA |
CTD |
PMID:23200776 |
|
NCBI chr 1:96,591,048...96,594,574
Ensembl chr 1:96,591,049...96,594,082
|
|
G |
Lep |
leptin |
multiple interactions decreases secretion |
EXP |
Diazoxide inhibits the reaction [[Glucose co-treated with INS1 protein] results in increased secretion of LEP protein] Diazoxide results in decreased secretion of LEP protein |
CTD |
PMID:10780946 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
multiple interactions |
ISO |
Diazoxide inhibits the reaction [Glucose results in increased secretion of NAMPT protein] |
CTD |
PMID:23536823 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases activity |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased activity of NFKB1 protein] |
CTD |
PMID:15326191 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein]]; Diazoxide inhibits the reaction [Rotenone results in increased expression of and results in increased activity of NOS2 protein] 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA]]; Diazoxide inhibits the reaction [Rotenone results in increased activity of NOS2 protein]; Diazoxide inhibits the reaction [Rotenone results in increased expression of NOS2 mRNA] |
CTD |
PMID:15795934 PMID:15927086 PMID:16257489 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
EXP |
Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of PDX1 mRNA] |
CTD |
PMID:11527545 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions |
EXP |
Diazoxide inhibits the reaction [Bezafibrate results in decreased expression of SLC2A2 mRNA] |
CTD |
PMID:11527545 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]]; Diazoxide inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein] |
CTD |
PMID:37783230 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion multiple interactions |
ISO EXP |
Diazoxide results in decreased secretion of TNF protein 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of TNF protein]]; 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased expression of TNF protein]]; Diazoxide inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased secretion of TNF protein]; Diazoxide inhibits the reaction [Rotenone results in increased expression of TNF protein] 5-hydroxydecanoic acid inhibits the reaction [Diazoxide inhibits the reaction [Rotenone results in increased secretion of TNF protein]]; Diazoxide inhibits the reaction [Rotenone results in increased secretion of TNF protein] |
CTD |
PMID:16257489 PMID:16612254 PMID:18700057 PMID:19012619 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
EXP |
Diazoxide results in decreased expression of TP53 mRNA |
CTD |
PMID:16426753 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases transport increases export |
ISO |
ABCC4 protein results in increased transport of Hydrochlorothiazide ABCC4 protein results in increased export of Hydrochlorothiazide |
CTD |
PMID:17135398 PMID:17939016 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Ace |
angiotensin I converting enzyme |
increases expression multiple interactions |
EXP |
Hydrochlorothiazide results in increased expression of ACE mRNA Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACE mRNA] |
CTD |
PMID:16326922 PMID:18796534 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of ACTA1 mRNA] |
CTD |
PMID:16326922 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression |
ISO |
Hydrochlorothiazide results in decreased expression of ADIPOQ mRNA |
CTD |
PMID:19730415 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
Hydrochlorothiazide results in decreased expression of AGTR1A mRNA |
CTD |
PMID:18796534 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Aqp2 |
aquaporin 2 |
decreases expression multiple interactions |
EXP |
Hydrochlorothiazide results in decreased expression of AQP2 mRNA; Hydrochlorothiazide results in decreased expression of AQP2 protein Hydrochlorothiazide inhibits the reaction [Lithium results in decreased expression of AQP2 protein] |
CTD |
PMID:15504936 PMID:17584643 |
|
NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:130,711,413...130,716,468
|
|
G |
Atp6v1b1 |
ATPase H+ transporting V1 subunit B1 |
increases expression |
EXP |
Hydrochlorothiazide results in increased expression of ATP6V1B1 protein |
CTD |
PMID:17311909 |
|
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
|
|
G |
Avp |
arginine vasopressin |
affects secretion |
ISO |
Hydrochlorothiazide affects the secretion of AVP protein |
CTD |
PMID:6635723 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Avpr2 |
arginine vasopressin receptor 2 |
decreases expression |
EXP |
Hydrochlorothiazide results in decreased expression of AVPR2 mRNA |
CTD |
PMID:17584643 |
|
NCBI chr X:151,633,501...151,636,155
Ensembl chr X:151,633,522...151,635,989
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
decreases expression |
EXP |
Hydrochlorothiazide results in decreased expression of BDKRB1 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP |
[Hydrochlorothiazide co-treated with Fructose] results in decreased activity of CAT protein Hydrochlorothiazide results in decreased activity of CAT protein |
CTD |
PMID:23707192 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
Hydrochlorothiazide results in decreased expression of CCL2 mRNA |
CTD |
PMID:19627010 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
EXP |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein |
CTD |
PMID:11318962 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions |
EXP |
[Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate affects the localization of CDKN2A protein]; [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of CDKN2A mRNA] |
CTD |
PMID:18504326 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cma1 |
chymase 1 |
affects expression |
EXP |
Hydrochlorothiazide affects the expression of CMA1 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
multiple interactions |
EXP |
Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of CYBA] |
CTD |
PMID:21107329 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of CYBB] |
CTD |
PMID:21107329 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
increases expression |
EXP |
Hydrochlorothiazide results in increased expression of CYP11B2 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of EDN1 mRNA] |
CTD |
PMID:16326922 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions |
EXP |
[Hydralazine co-treated with Hydrochlorothiazide] inhibits the reaction [Cyclosporine results in increased expression of FLT1 mRNA] |
CTD |
PMID:12110003 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Klk1 |
kallikrein 1 |
increases expression |
EXP |
Hydrochlorothiazide results in increased expression of KLK1 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Lepr |
leptin receptor |
increases response to substance |
ISO |
LEPR mutant form results in increased susceptibility to Hydrochlorothiazide |
CTD |
PMID:22949526 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Mr1 |
major histocompatibility complex, class I-related |
affects expression |
ISO |
Hydrochlorothiazide affects the expression of MR1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of MYH7 mRNA] |
CTD |
PMID:16326922 |
|
NCBI chr15:28,446,550...28,469,888
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] |
CTD |
PMID:16197366 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
EXP |
Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of NOX1] |
CTD |
PMID:21107329 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
Hydrochlorothiazide promotes the reaction [candesartan results in decreased expression of NOX4] |
CTD |
PMID:21107329 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of NPPB mRNA] |
CTD |
PMID:16326922 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases expression |
EXP |
Hydrochlorothiazide results in increased expression of NR3C2 mRNA |
CTD |
PMID:18796534 |
|
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein |
CTD |
PMID:11318962 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[rofecoxib results in decreased activity of PTGS2 protein] inhibits the reaction [Hydrochlorothiazide results in increased abundance of Prostaglandins] |
CTD |
PMID:11703585 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ramp2 |
receptor activity modifying protein 2 |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP2 protein] |
CTD |
PMID:16326922 |
|
NCBI chr10:86,187,366...86,190,692
Ensembl chr10:86,188,812...86,231,829
|
|
G |
Ramp3 |
receptor activity modifying protein 3 |
multiple interactions |
EXP |
Hydrochlorothiazide inhibits the reaction [Nitric Oxide deficiency results in increased expression of RAMP3 protein] |
CTD |
PMID:16326922 |
|
NCBI chr14:81,527,404...81,544,905
Ensembl chr14:81,527,385...81,544,902
|
|
G |
Ren |
renin |
increases activity increases expression multiple interactions |
ISO EXP |
Hydrochlorothiazide results in increased activity of REN protein Hydrochlorothiazide results in increased expression of REN protein Losartan promotes the reaction [Hydrochlorothiazide results in increased expression of REN protein]; Sodium affects the reaction [Hydrochlorothiazide results in increased activity of REN protein] |
CTD |
PMID:1930859 PMID:2920503 PMID:11135058 PMID:12569265 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
affects expression |
ISO |
Hydrochlorothiazide affects the expression of HLA-E mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
RT1-CE5 |
RT1 class I, locus CE5 |
affects expression |
ISO |
Hydrochlorothiazide affects the expression of HLA-F mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,403,418...3,479,476
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
affects expression |
ISO |
Hydrochlorothiazide affects the expression of HLA-DRB1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
RT1-Ha |
RT1 class II, locus Ha |
affects expression |
ISO |
Hydrochlorothiazide affects the expression of HLA-DPA1 mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
EXP |
[troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein |
CTD |
PMID:11318962 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
increases expression |
EXP |
Hydrochlorothiazide results in increased expression of SLC22A6 protein |
CTD |
PMID:12897087 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
|
G |
Slc12a7 |
solute carrier family 12 member 7 |
decreases activity |
ISO |
Trichlormethiazide results in decreased activity of SLC12A7 protein |
CTD |
PMID:10913127 |
|
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:29,472,692...29,554,302
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
multiple interactions |
ISO |
Trichlormethiazide inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Trichlormethiazide affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
decreases activity |
ISO |
Trichlormethiazide results in decreased activity of TPMT protein |
CTD |
PMID:8866635 |
|
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
|
|